不同年龄段老年髋部骨折手术患者的临床特征及结局

注册号:

Registration number:

ChiCTR2400084758 

最近更新日期:

Date of Last Refreshed on:

2024-05-24 08:34:26 

注册时间:

Date of Registration:

2024-05-24 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

不同年龄段老年髋部骨折手术患者的临床特征及结局

Public title:

Clinical Characteristics and Outcomes of Elderly Patients with Hip Fracture in Different Age Groups

注册题目简写:

English Acronym:

研究课题的正式科学名称:

不同年龄段老年髋部骨折手术患者的临床特征及结局

Scientific title:

Clinical Characteristics and Outcomes of Elderly Patients with Hip Fracture in Different Age Groups

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

于爱兰 

研究负责人:

于爱兰 

Applicant:

Yu Ailan 

Study leader:

yuailan 

申请注册联系人电话:

Applicant telephone:

+86 13346255809

研究负责人电话:

Study leader's
telephone:

+86 13563530309

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

yuercai@126.com

研究负责人电子邮件:

Study leader's E-mail:

yuercai@126.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

山东省聊城市东昌府区东昌西路67号

研究负责人通讯地址:

山东省聊城市东昌西路67号

Applicant address:

67 Dongchang Road West, Dongchangfu District, Liaocheng, Shandong

Study leader's address:

No. 67 Dongchang West Road, Liaocheng, Shandong

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

聊城市人民医院

Applicant's institution:

Liaocheng People's Hospital

研究负责人所在单位:

聊城市人民医院

Affiliation of the Leader:

Liaocheng People's Hospital

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2024102

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

医院医学伦理委员会

Name of the ethic committee:

Ethics Committee of Liaocheng People's Hospital

伦理委员会批准日期:

Date of approved by ethic committee:

2024-05-16 00:00:00

伦理委员会联系人:

唐哲栋

Contact Name of the ethic committee:

Tang ZheDong

伦理委员会联系地址:

山东省聊城市东昌西路67号

Contact Address of the ethic committee:

No. 67 Dongchang West Road, Liaocheng, Shandong

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 635 8275750

伦理委员会联系人邮箱:

Contact email of the ethic committee:

tangzhedong@sina.com

研究实施负责(组长)单位:

聊城市人民医院

Primary sponsor:

Liaocheng People's Hospital

研究实施负责(组长)单位地址:

山东省聊城市东昌西路67号

Primary sponsor's address:

No. 67 Dongchang West Road, Liaocheng, Shandong

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

山东

市(区县):

Country:

China

Province:

Shandong

City:

单位(医院):

聊城市人民医院

具体地址:

山东省聊城市东昌西路67号

Institution
hospital:

Liaocheng People's Hospital

Address:

No. 67 Dongchang West Road, Liaocheng, Shandong

经费或物资来源:

自选课题(自筹)

Source(s) of funding:

self-financing

研究疾病:

髋部骨折  

Target disease:

Hip fracture

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

队列研究 

Study design:

Cohort study 

研究目的:

分析不同年龄段老年髋部骨折患者的的临床特征和结局  

Objectives of Study:

To analyze the clinical features and outcomes of elderly patients with hip fracture at different ages

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

1.病历资料缺失或失访;
2.严重的复合伤;
3.无法取得患者或家属知情同意;

Exclusion criteria:

1.Medical records are missing or inaccessible;
2.Severe compound injury;
3.Unable to obtain informed consent from the patient or family;

研究实施时间:

Study execute time:

From 2024-05-15 00:00:00 To 2024-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2024-05-24 00:00:00 To 2024-12-31 00:00:00

干预措施:

Interventions:

组别:

年轻老年人组

样本量:

332

Group:

YO group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

组别:

中年老年人组

样本量:

337

Group:

MO group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

组别:

高龄老年人组

样本量:

240

Group:

HO group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

山东 

市(区县):

 

Country:

China

Province:

Shandong

City:

单位(医院):

聊城市人民医院 

单位级别:

三级甲等 

Institution
hospital:

Liaocheng People's Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

手术患者的临床特征及结局

指标类型:

主要指标

Outcome:

Clinical features and outcomes of surgical patients

Type:

Primary indicator

测量时间点:

出院时、术后30天、术后90天

测量方法:

住院资料来源于聊城市人民医院电子病历系统(曼荼罗电子病历平台)和Docare手术麻醉系统。出院后的转归情况通过电话随访

Measure time point of outcome:

At discharge, 30 days after surgery, and 90 days after surgery

Measure method:

Hospitalization data came from Liaocheng People's Hospital electronic medical record system (Mandala electronic medical record platform) and Docare anesthesia system. The outcomes after discharge were followed up by telephone

指标中文名:

一般资料

指标类型:

次要指标

Outcome:

General information

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

NA

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 65 years
最大 Max age 103 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

None

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

None

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

暂无

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

NIL

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

1、医渡云数据库 2、手术麻醉系统 3、新版病历系统

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

1. Yidu cloud database 2. Surgical anesthesia system 3. New medical record system

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2024-05-24 08:34:09